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LETTER TO THE EDITOR
THE CLOSE RELATIONSHIP BETWEEN TOXOPLASMOSIS AND KIDNEY FUNCTION
August 29, 2012
Dear Sir
The recent article by TOPOROVSKY et al. was highly interesting9. The association of toxoplasmosis and renal function extends beyond nephrotic 
syndrome. 
For instance, toxoplasmosis is common after renal transplantation. An incidence rate of 0.14 % was reported in a recent study3. GHARAVI et al. 
in another study have reported secondary infection in 3% of renal transplant patients4. Primary infection usually occurs in a majority of the patients 
with incidence as high 81.8% being reported. Sero-negative patients are 15 times more likely to develop toxoplasmosis following renal transplant. 
Toxoplasmosis secondary to renal transplantation is associated with significant morbidity. The median time to diagnosis of toxoplasmosis following 
renal transplantation is about 92 days3. Mortality rates as high as 14% have been reported. Toxoplasma infection usually causes enlargement of the 
spleen and lymphadenopathy. Atypical cerebral toxoplasmosis may occur following renal transplantation2. Encephalitis secondary to toxoplasmosis 
infection may occur in chronic renal failure patients secondary to immunosuppressive steroid therapy. Other patients may develop brain abscess. 
Lung infestation may result in pneumonia. Similarly cardiac tissue can be affected resulting in myocarditis. Rarely left ventricular failure has been 
reported7. Hemo-phagocytic syndrome is another rare manifestation of post transplantation toxoplasmosis5. 
Enzyme-linked immunosorbent assay (ELISA) and enzyme-linked fluorescence assay (ELFA) tests are commonly used in detecting anti-Toxoplasma 
antibodies in renal transplant recipients8. NISSAPATORN et al. in a recent study have reported an overall sero-prevalence of latent toxoplasmosis of 
51% in renal patients. The highest positivity rate for anti-Toxoplasma IgG & IgM antibodies is seen in the 20 years to 30 years age group6. In chronic 
renal failure the risk of toxoplasmosis is increased with higher exposure to dialysis. Anti-Toxoplasma IgM antibodies are detected in sero-positive 
patients following renal transplants during the first year in nearly 86% of patients. Nearly 57% of patients on hemodialysis demonstrate anti-Toxoplasma 
IgG antibodies in one recent study1. All renal transplant donors should be screened for anti-Toxoplasma IgM antibodies. Infact, all renal transplant 
recipients should be administered trimethoprim/sulfamethoxazole for at least half a year following renal transplantation. 
The above examples clearly illustrate the close association between toxoplasmosis and renal function and the need to fully screen renal transplant 
patients for toxoplasmosis. 
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